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Introduction. Myotonia permanens due to Nav1.4-G1306E is a ra-
re sodium channelopathy with potentially life-threatening respira-
tory complications. Our goal was to study phenotypic variability 
throughout life. 
Methods. Clinical neurophysiology and genetic analysis were per-
formed. Using existing functional expression data we determined 
the sodium window by integration. 
Results. In 10 unrelated patients who were believed to have epi-
lepsy, respiratory disease or Schwartz-Jampel syndrome, we made 
the same prima facie diagnosis and detected the same heterologous 
Nav1.4-G1306E channel mutation as for our first myotonia per-
manens patient published in 1993. Eight mutations were de-novo, 
two were inherited from the affected parent each. Seven patients 
improved with age, one had a benign phenotype from birth, and 
two died of respiratory complications. The clinical features age-
dependently varied with severe neonatal episodic laryngospasm 
in childhood and myotonia throughout life. Weakness of varying 
degrees was present. The responses to cold, exercise and warm-up 
were different for lower than for upper extremities. Spontaneous 
membrane depolarization increased frequency and decreased size 
of action potentials; self-generated repolarization did the opposite. 
The overlapping of steady-state activation and inactivation curves 
generated a 3.1-fold window area for G1306E vs. normal channels. 
Discussion. Residue G1306 Neonatal laryngospasm and unusual 
distribution of myotonia, muscle hypertrophy, and weakness en-
courage direct search for the G1306E mutation, a hotspot for 
de-novo mutations. Successful therapy with the sodium channel 
blocker flecainide is due to stabilization of the inactivated state and 
special effectiveness for enlarged window currents. Our G1306E 
collection is the first genetically clarified case series from newborn 
period to adulthood and therefore helpful for counselling.
Key words: muscular and respiratory tract diseases, neonate, stri-
dor
Introduction
Myotonia is defined as slowed muscle relaxation 
after voluntary contraction. It is experienced by patients 
as muscle stiffness. Symptoms are caused by recessive or 
dominant mutations in the ClC1 chloride channel or by 
dominant mutations in the Nav1.4 sodium channel of 
skeletal muscle. Typically, myotonia lessens with muscle 
usage, the so-called warm-up phenomenon. However, not 
all forms of myotonia have a warm-up phenomenon. For 
example, there is a rare form of myotonia whose severity 
never varies and is therefore termed myotonia perman-
ens. This phenotype was originally acknowledged by (1) 
as new entity in a patient (Table 1, patient 4) previously 
published elsewhere (2). The phenotype is characterized 
by severe, continuous myotonia associated with a unique 
EMG pattern of persistent myotonic activity. Addition-
ally, stiffness and hypertrophy of facial, bulbar, neck and 
shoulder muscles and episodes of respiratory distress are 
predominant features. The underlying SCN4A mutation 
encodes p.G1306E, a glycine-to-glutamate substitution. 
G1306 is highly conserved in all voltage-gated sodium 
channels and situated in the fast inactivation gate of the 
sodium channel Nav1.4 i.e., the intracellular loop con-
necting domains III and IV of the channel protein. The 
main pathogenetic mechanism is thought to be a slowed 
and incomplete channel inactivation (2).
Alongside epilepsy and respiratory diseases, the dis-
order has been diagnosed as myogenic type of Schwartz-
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Table 1. Life course of myotonia permanens patients with the SCN4A-p.G1306E mutation. Abbreviations: CMZ, carbamazepine; DPH, diphenylhydantoin. * DPH reduced apnoeic episodes but not the myotonia; SNEL, severe neonatal episodic laryngospasm; 
R, added to the patient number, means a relative. Symbols: + present; - absent; (+) mild; 0 mother and 5 siblings healthy and G1306E excluded, father with no history of myotonia; · parents deceased with no history of myotonia; 2 siblings, both healthy.
Patient 
number
Current 
age Gender
Neonatal 
onset
De-novo 
G1306E
Age of 
examination
Inspiratory 
stridor Laryngospasms
Loss 
of 
consciousness
Hypertrophy 
& myotonia 
Painful
muscle 
cramps
Persistent 
EMG 
activity Weakness
Factors which 
provoke myoto-
nia and respi-
ratory distress 
throughout life
Medication 
response 
to Remarks Course during life
1 22 m + + Birth
2 y
3.5 y
7 y
13 y
22 y
+
+
+
+
-
+
+
+
+
+
+
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
-
-
-
-
Heat
exercise
See text Disease misinterpreted as 
laryngomalacia, epilepsy; 
bent posture; 
failure to thrive
SNEL
reduction, 
constant 
myotonia
2 8 f + + Birth
5 y
-
-
+
-
-
-
-
+ + +
-
-
K-rich food; 
frequent 
suffocation after 
oral liquid intake
Mexiletine Large tongue, failure to thrive; if 
falling unable to get up for 2min 
SNEL 
reduction, 
constant 
myotonia 
3 2 f + + 1 mo
1 y
2 y
+
+
+
+
+
+
-
-
-
+
+
+
+
+
+
-
-
-
Infections, 
K-rich food, 
coldness
CMZ, mexiletine 
effective. Not effective: 
acetazolamide
aggravation by 
penicilline
Disease misinterpreted as 
epilepsy, tracheomalacia; bent 
posture, rotated arms, swallowing 
of liquids impaired, clenched 
hand
SNEL 
reduction, 
constant 
myotonia 
4 50 f + +° Birth
6 y
26 y
36 y
+
+
-
-
+
+
(+)
(+)
+
+
-
-
+
+
+
+
+
+
+
+
+
+
-
-
-
-
Cortico-steroid,
stress, infection, 
exercise, 
pregnancy
Barbiturate,
flecainide 
superior to mexiletine, 
CMZ, tocainide, 
quinidine
Disease misinterpreted as 
epilepsy, SJS 
Lerche et al. 1993
Desaphy et al. 2013
SNEL 
reduction, 
constant 
myotonia 
4R 12 m + - Birth
5 y
+
-
+
-
-
-
+
+
+
+ +
-
-
Flecainide 
superior to mexiletine
Rotated arms, Desaphy et al. 
2013; severe  orbicularis, eye-
lid, tongue m.
SNEL 
reduction, 
constant 
myotonia 
5 17 m + + Birth
3 mo
1.5 y
10 y
17 y
+
+
+
-
-
+
+
+
-
-
+
-
-
-
-
-
+
+
-
-
-
+
+
+
+
+
-
-
-
-
-
Sleep, coldness Mexiletine 
superior to 
CMZ, DPH*
Disease misinterpreted as 
epilepsy, SJS;
no painful cramps 
SNEL 
reduction, 
constant 
myotonia 
6 63 f + +‘ Infant
42-63 y
+
-
+
-
-
-
+
+
+
+
+
+
(+) Exercise, 
coldness, 
K-rich food
Effective are 
flecainide, to-cainide. 
not effective are: 
mexiletine, lamotrigine 
SNEL 
reduction, 
constant 
myotonia 
7 50 m + + 3 mo
6 mo
41-46 y
+
+
-
+
+
-
+
+
-
+
+
+
+
+
+ +
-
-
+
Exercise Mexiletine Disease misinterpreted as 
epilepsy, stomach hiatus, painful 
rectus cramping, bent posture
SNEL 
reduction, 
constant 
myotonia 
8 67 m - + 9 mo
Adult
-
-
-
-
-
-
+
+
+
+ ?
-
-
Exercise Mexiletine Mild phenotype Constant 
myotonia 
9 - m + + 1 mo
3 mo
11 y
+
+
-
+
+
+
+ +
+
+
+
+
+
+ Coldness, 
exercise
Heat, 
dilantin, desipramine
Died at age 11 y of 
cardiorespiratory insufficiency 
due to severe myotonic reaction
Lethal
9R1 22 m - - Birth
4 mo
1 y
22 y
-
+
+
-
-
+
+
-
-
-
-
-
-
-
+
+
+
+
+
+ Coldness, 
elevated K+
Dilantin, desipramine Weakness neck, shoulder girdle, 
upper arms
SNEL 
reduction, 
constant 
myotonia
9R2 43 f + + 5 day
14 mo
+
+
+
+
-
-
+
+
+
+
+
+
Pain, cold, 
exercise
Dilantin, desipramine Succinylcholine-induced event SNEL 
reduction, 
constant 
myotonia
10 - m + + Birth
9 mo
20 mo
4 y
21 y
-
+
+
-
+
+
-
-
-
-
+
+
+
+
+
+
+
+
+
+
-
-
-
-
Excitement Mexiletine Bent posture, failure to thrive, 
died at age 22 y
Lethal
127126
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Jampel syndrome (3, 4). Next to severe cases with poten-
tially lethal laryngospasm, a very mild case of myotonia 
permanens has been reported (1). The questions on sever-
ity and prognosis are still a matter of debate. Although 
myotonia permanens is a rare entity, it is important that 
a pediatrician is familiar with this sodium channelopathy 
because it is life- threatening but treatable and, usually, 
misdiagnosed. Only limited clinical information is avail-
able in pediatric handbooks. This led us to pool 10 unrelat-
ed cases to evaluate the spectrum and phenotypic changes 
during the course of life (Table 1).
Patients and methods
Patients 
The study was approved by the Ethics Committee 
of Ulm University. Written informed consent was taken 
from patients or their parents for publishing their pictures, 
clinical and genetic examination, and study of their his-
tory.
Genetics
Whole EDTA blood was drawn for extraction of 
genomic DNA. Using primers specific for exon 22 and 
the corresponding exon-intron boundaries (2), DNA was 
amplified by PCR and products bi-directionally sequenced 
with Applied Biosystems BigDye terminator v3.1 as per 
the manufacturer’s instructions. The resulting sequencing 
reactions were resolved on an ABI3730 genetic analyzer 
(Applied Biosystems, Foster City, CA).
Excised muscle experiments
Previously unpublished experiments of excised 
quadriceps fiber segments obtained from patient 4 in 
1993 were performed using capacity-compensated mi-
croelectrodes of 3-5 MOhm. Twitch force was analyzed 
for 3; 5; and 7 mM potassium (2, 4). The force of the mus-
cle bundles, which were mounted in a sylgard-bottomed 
chamber, superfused at 37°C and stimulated supramaxi-
mally with single pulses of 0.2 ms duration, were meas-
ured with a strain gauge. The standard solution contained 
(in mM): NaCl 107.7; KCl 3.48; CaC1
2
 1.53; MgSO
4
 
0.69; NaHCO
3
 26.2; NaH2P0
4
 1.67; Na gluconate 9.64; 
glucose 5.5; sucrose 7.6 (315 mosm/l). The pH was ad-
justed to 7.4 by 95% 0
2
 and 5% CO
2
.
Re-evaluation of published results
Our previously published data on heterologously ex-
pressed G1306E and wildtype (WT) Nav1.4 channels 
in HEK cells from 1995 (5) were re-evaluated, particu-
larly, to demonstrate the presence of a sodium window 
current in the mutant and to compare the percentage of 
sodium channels which can be activated at near-threshold 
potentials. Data points for steady-state activation (g/V) 
and steady-state inactivation were fitted by applying the 
Boltzmann function for the distribution of two-states 
(closed and open channels). The fits were used to deter-
mine the sodium window by integration.
Results
Genetics
All ten patients harbored a heterozygous SCN4A mu-
tation c.3917G>A encoding G1306E in the major volt-
age-gated Nav1.4 sodium channel of skeletal muscle. In 
eight independent cases, the mutation recurred de-novo; 
in two families, affected relatives inherited the mutation 
in an autosomal dominant fashion (4R, 9R1, 9R2, Table 
1). None of the unaffected parents or healthy siblings car-
ried the mutation.
Clinical features over time
In the neonatal period, patients experienced episodes 
of severe laryngospasms, resulting in acute hypoventila-
tion and cyanosis and, in five patients, unconsciousness 
(Table 1). For example, these episodes occurred up to sev-
eral times per day and demanded mask ventilation or an 
oxygen supply in patient 1 (Fig. 1). Such cyanotic spells 
were life-threatening and required recurrent hospitaliza-
tion of up to six months each. Several spells led to apnoea 
(SO2=30%), opisthotonus, and unconsciousness and re-
sponded to barbiturate. In half of the patients, cyanotic 
episodes associated with apnoea and falls were interpret-
ed as epileptic seizures even though the EEG was normal. 
This view was supported by the beneficial response to the 
administration of carbamazepine and barbiturates, drugs 
which block sodium channels and exert antimyotonic 
effects. Startling and sucking elicited the laryngospasm 
which was initially mistaken for laryngomalacia or gas-
troesophageal reflux. Chewing and swallowing was also 
impaired, leading to a transient failure to thrive in three 
patients.
In infancy and early childhood, an inspiratory stridor 
occurred in 80% of the patients. An example for an inspir-
atory stridor is shown in Figure 2 (patient 3) and the video 
(stridor.avi). Stridor EEG readings during awake, drowsy, 
and asleep states were normal. These patients developed 
episodes of shortness of breath when startled or during 
mental stress later in life, i.e. in adolescence and adult-
hood. These symptoms responded to anti-myotonic treat-
ment. It is important to note that respiratory difficulties 
p.G1306E phenotype
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can worsen during anesthesia with muscle relaxants: at 11 
years of age, patient 9 experienced increasing respiratory 
distress during general anesthesia and died of cardiores-
piratory insufficiency due to a severe myotonic reaction, 
which was associated with initial jaw clenching and late 
occurrence of hyperkalemia and increased body tempera-
ture resembling a malignant-hyperthermia-like event.
In pre-school childhood, the habitus showed slow 
movements, excessive sweating and open mouth with 
drooling. In four patients, shoulder girdle and arms were 
typically rotated inwardly, with elevated shoulders, ante-
ro-flexion of the trunk (patient 1, Fig. 3A), and a bell-
shaped thorax (patient 2, Fig. 3B). One patient, originally 
diagnosed with Schwartz-Jampel syndrome (SJS) (3) had 
laryngeal stridor, high-pitched voice, mask-like facies, 
myotonic and hypertrophic shoulder, neck and upper arm 
muscles (patient 10, Fig. 4A-C). Movements were scarce 
and slow. During locomotion there was toe-walking and 
the arms were held in semi-flexion.
Myotonia was present at all ages. Continuous muscle 
activity superimposed by myotonic bursts could be re-
corded in the EMG of the affected muscles, even dur-
ing sleep. If a patient was startled, the EMG activity 
transiently increased further. Myotonia worsened with 
potassium- rich food in all three patients. Unexpectedly, 
the clinical responses of some muscle groups differed 
considerably. In facial and bulbar muscles, the myoto-
nia worsened during repetitive exercise and cooling. Lid 
muscles were especially sensitive to cold and presented 
with paradoxical lid myotonia, even more extreme than 
in paramyotonia. In contrast, the myotonia disappeared in 
cooled forearm muscles. Trunk and upper extremities did 
Fig. 1. Patient 1 with neonatal respiratory distress as in-
fant. In infancy and childhood, laryngospasm and myo-
tonic stiffness of the ventilatory muscles resulted in cya-
nosis and demanded oxygen supply.
Fig. 2. Still image of the inspiratory stridor of patient 3 in 
the first month of life. The image is associated by a video 
(stridor.avi).
Fig. 3. A: Patient 1 with bent posture in childhood. B: 
Patient 2 with bell-shaped thorax and inwardly rotated 
shoulder girdle and pectoralis muscles. Note the hyper-
trophy of neck muscles and the mentalis.
A B
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not show warm-up phenomenon so that patients were un-
able to arise from floor for minutes after falling, however, 
the lower extremities showed a warm-up phenomenon 
much like that in recessive, chloride channel myotonia. 
A milder phenotype with interrupted EMG activity was 
observed in one patient who originally had the clinical di-
agnosis of Becker myotonia and no respiratory episodes 
in childhood (patient 8).
Muscle hypertrophy was also present at all ages (Ta-
ble 1). It was most pronounced in neck, face (particular 
the mentalis muscle), bulbar, shoulder and proximal arm 
muscles as shown for patient 3 (Fig. 5A), patient 4R (Fig. 
5B), patient 5 (Fig. 5C), and patient 4 (Fig. 5D), the mother 
of the boy 4R. She enabled us to coin the term myotonia 
permanens as new entity. The hypertrophy corresponded 
well with myotonia and with painful cramps of working 
muscles, outlasting subsequent rest from which 90% of 
patients suffered. Motor development was delayed when 
without treatment.
Surprisingly, we found several instances of muscle 
weakness in the patients. One patient presented with hy-
potonia at birth and 40% of all patients presented with 
episodic or mild continuous weakness (Table). The epi-
sodes ranged from relatively sudden events of lower 
limbs for a few days with consequent falling (patient 7) 
up to mild but fixed proximal leg weakness (patient 6). 
Patient 10 had a weak such as an infant.
Generally, myotonic symptoms responded to antie-
pileptic and antiarrhythmic drugs. Since carbamazepine 
caused adverse effects at higher dosages, mexiletine and 
flecainide were most frequently used. Our patients gen-
erally preferred flecainide since, for example, flecainide 
was able to suppress the continuous activity completely 
when muscles were at rest (patient 6).
Excised muscle experiments
Muscle fiber segments obtained from patient 4 
showed spontaneous membrane depolarizations similar 
to those previously published for patient 10 (4). The de-
polarizations were followed by intracellular myotonic 
bursts consisting of waxing action potential frequency 
and waning amplitude with subsequent self-generated 
repolarization characterized by an inverse pattern (Fig. 
6). Pathological spontaneous muscle activity and twitch 
forces revealed an approximately 4-fold higher am-
plitude after elevation of potassium from 3 to 7 mM. 
Fig. 4. Boy (patient 10) with postnatal laryngospasm and myotonia at age of 4.5 (A, B) and 11 years (C). A: Toe walk-
ing associated with involuntary closing the fists; B: The boy was asked to close his eyes whereby he also activated 
his mouth and other facial muscles; due to the myotonic stiffness of the hypertrophic muscles, the patient often fell 
following a sudden movement and injured himself. C: Short neck and hypertrophic neck and shoulder girdle muscles. 
Prior to detection of a G1306E sodium channel mutation causing myotonia permanens, the patient was thought to have 
a myogenic form of Schwartz-Jampel syndrome.
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Forearms cooled in water of 15°C for 30 min had the 
same effect, however, rewarming completely abolished 
myotonia.
Evaluation of fit parameters using the current dots 
published in our G1306E/V/A paper (5) 
Using Boltzmann distribution I/Imax = A/(1+exp((V-
V0.5)/k))+I0, the best current fits of the dots of the 
steady-state curves were achieved for the following pa-
rameters: for inactivation of WT channels: A = 0.98, 
V0.5 = -56 ± 1 mV, k = 9.1 mV; and for inactivation of 
G1306E channels A = 0.95, V0.5 = -41 ± 1 mV, k = 8.3 
mV (N = 8-12). The amplitude factors A and the slopes 
k did not differ significantly between WT and G1306E, 
only the 15 mV right-shift of the inactivation curve was 
significant (p < 5%) (Fig. 7 A). The fit parameters for ac-
tivation of WT channels were: A = 0.95, V0.5 = -11.5 ± 1 
mV, k = -7.2 mV and for activation of G1306E channels 
A = 0.95, V0.5 = -17±1 mV, k =  -7.1 mV (N = 8-12). 
While A were the same, k did not substantially differ and 
I0 was zero, the midpoint of G1306E channel activation 
Fig. 5. Myotonic stiffness and muscle hypertrophy in 4 patients at different ages. Note the short neck and the hypertroph-
ic shoulder, back and upper arm muscles. A: infancy (patient 3), B: childhood (patient 4R), C: adolescence (patient 5), 
D: Adulthood (patient 4); the picture shows the face of the first patient world-wide who was reported by Lerche et al. 
1993 under the diagnosis of myotonia permanens. Note the blepharospasm.
Fig. 6. Intracellular recording of a so far unpublished my-
otonic burst from a freshly excised muscle fiber of patient 
4 when she was biopsied in 1993.
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was shifted significantly to the left by 5.5 mV (p < 5%) 
(Fig. 7B). This left-shift led to a decreased electrical 
threshold that increases muscle excitability. Additionally, 
we determined the percentage of channels, which could 
be opened near the electrical threshold of approximately 
-65 mV: 89% of G1306E and 72% of WT channels (Fig. 
7A).
Window currents and their integration
The superimposition of the steady-state curves for 
inactivation and activation showed an overlap which cor-
responded to the window currents for WT and G1306E 
(Fig. 7C). For the integration of the window currents, 
the above mentioned Boltzmann distribution for the two 
channel states (open = activated and closed = inactivated) 
was used. The increased window current was caused by 
the left-shift of activation and the right-shift of inactiva-
tion. These shifts produced an approximately 3-fold 
G1306E window current at -30 mV and a 3.1-fold win-
dow area for G1306E vs. normal channels. The increased 
computed areas i.e., the integral sodium influx may gen-
erate weakness by depolarizing the membrane close to 
the threshold and inactivating co-existing wildtype chan-
nels in vivo. Due to kinetic and steady- state properties 
that depend on each other, the right-shift of the inactiva-
tion curve increases the number of „activatable“ channels 
at physiologically relevant test voltages. This peculiar 
property of the G1306E channel may further contribute to 
the severe and permanent myotonia.
Discussion
Clinical features
Our study is the first to examine a G1306E co-
hort from the neonatal period to adulthood. It expands 
knowledge of the phenotype presented in previous sin-
gle case reports and enables early prima facie diagno-
sis which changes the patient´s life. The presence of 
postnatal respiratory symptoms such as laryngospasm 
and stridor has been described for several Nav1.4 muta-
tions including G1306E, I693T, A799S, N1297K, and 
T1313M (2, 6-13). Also for the milder myotonia fluc-
tuans caused by G1306A, severe postnatal cyanosis has 
been reported (14). A milder G1306E phenotype we 
found in one patient is similar to (1) who reported fa-
ther and son with severe myotonia aggravated by exer-
cise and potassium, but only moderate impairment by 
the condition, even without treatment. In contrast, the 
presence of various degrees of weakness and the differ-
ent reactions to exercise (exacerbation or warm-up) and 
cold (exacerbation or disappearance of myotonia) have 
not yet been reported. This could be due to the physical 
examinations focusing on muscle especially affected by 
myotonia (eyelid and hand) for diagnosis whilst ignor-
ing the lower extremities.
Differential diagnoses
Paroxysmal motor phenomena, obstructive sleep 
apnoea, opisthotonus, and unconsciousness may have 
led to the frequent suspicion of the diagnosis epilepsy in 
newborns. However these paroxysmal motor phenom-
ena in euglycemic neonates are most likely brain stem 
release signs (15). Epileptic activity was finally exclud-
ed by several conventional and special EEGs such as 
video-EEG. Another differential diagnosis, the very rare 
Schwartz-Jampel syndrome (SJS), requires more exten-
sive clinical, radiological, and EMG investigation. SJS 
is characterized by delayed onset after birth, blepharos-
pasms and mask-liked face, reduced tendon reflexes, and 
short stature (16). Lack of osteochondrodysplasia in the 
x- ray is an exclusion criterion. The atypical myotonia 
in SJS can be confirmed by EMG because the discharges 
are neurogenic and characterized by high frequency and 
low voltage. Since the existence of a myogenic SJS has 
long been disproven, we encourage to drop this term in 
the future.
Pathogenesis and treatment
Until now, mainly the degree of the slowing of kinet-
ics of inactivation with destabilization of the inactivated 
state was held responsible for the clinical severities of 
the Nav1.4 mutations G1306A, G1306V, and G1306E 
(5,17). Our evaluation suggests that i) lowering of the 
G1306E threshold, ii) increased window currents, and iii) 
increased mutant channel availability at near-threshold 
potentials may contribute decisively to the phenotype. 
Additionally, the window current may explain the 
increased effectivity of flecainide as shown for the ho-
mologous heart Nav1.5 channel (18, 19). Flecainide can 
be started in the neonatal period and will permit a life-
long treatment of symptoms (7, 20).
Conclusions
Myotonia permanens is a very rare disease. Our col-
lection of 10 unrelated patients is a genetically clarified 
case series from newborn period to adulthood and is rel-
evant for parent counselling and early prima facie diag-
nosis. Unusual distribution of myotonia, muscle hyper-
trophy, and weakness should not exclude a genetic test 
for the G1306E mutation – especially if laryngospasm 
or respiratory difficulties are present – because therapy is 
available: flecainide.
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Fig. 7. A-C: Measured values (spots) and Boltzmann fits (lines) of steady-state inactivation (A) and steady-state acti-
vation (B) for normal (WT) and G1306E (GE) mutant channels. The currents were normalized to the maximum sodium 
current. The deviation between spots (dashedlines) and fits (continuous lines) is minimal for WT and neglectable for 
physiologically relevant voltages of the mutant channel. The percentage of channels which are not inactivated at an 
electrical threshold of -65 mV is higher for G1306E (92%) than for WT (75%). As steady-state inactivation at 0 mV was 
induced by a relatively short 35-ms pulse to the indicated test voltage, we also applied 500-ms prepulses and found 
no change in the size of the shift. C: The overlapping area (box) of the fits in A and B shows the current size and the 
voltage range of the window current. The two triangles were used for integration.
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